Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Alcon Research |
---|---|
Information provided by: | Alcon Research |
ClinicalTrials.gov Identifier: | NCT00818805 |
To evaluate the efficacy of olopatadine 0.1% using the OHIO Chamber in patients with seasonal allergic conjunctivitis.
Condition | Intervention | Phase |
---|---|---|
Allergic Conjunctivitis |
Drug: Olopatadine 0.1% Drug: Tranilast 0.5% |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind (Subject), Crossover Assignment |
Enrollment: | 50 |
Study Start Date: | July 2008 |
Primary Completion Date: | July 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
Olopatadine 0.1%
|
Drug: Olopatadine 0.1%
one drop
|
2: Placebo Comparator
Tranilast ophthalmic solution 0.5%
|
Drug: Tranilast 0.5%
one drop
|
Ages Eligible for Study: | 20 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | ( Takahiro Nakagawa ) |
Study ID Numbers: | AL-292ET |
Study First Received: | January 7, 2009 |
Last Updated: | January 7, 2009 |
ClinicalTrials.gov Identifier: | NCT00818805 |
Health Authority: | Japan: Institutional Review Board |
conjunctivitis |
Otorhinolaryngologic Diseases Conjunctivitis, Allergic Eye Diseases SARS Rhinitis Conjunctivitis Olopatadine Conjunctival Diseases |
Histamine Tranilast Hypersensitivity Respiratory Tract Diseases Rhinitis, Allergic, Seasonal Hypersensitivity, Immediate Histamine phosphate Respiratory Hypersensitivity |
Anti-Inflammatory Agents Neurotransmitter Agents Immune System Diseases Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Histamine Agents Anti-Allergic Agents Nose Diseases Pharmacologic Actions Histamine Antagonists |
Sensory System Agents Analgesics, Non-Narcotic Therapeutic Uses Histamine H1 Antagonists Anti-Inflammatory Agents, Non-Steroidal Peripheral Nervous System Agents Analgesics Antirheumatic Agents Histamine H1 Antagonists, Non-Sedating Central Nervous System Agents |